相关实验视频

Updated: May 7, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

癌症风险因素是否影响CT/MRI与癌症的主要特征的关联? 一个个参与者的数据元分析

Robert G Adamo¹, Eric Lam², Jean-Paul Salameh¹

¹Faculty of Medicine at The University of Ottawa, Ottawa, ON, Canada.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes

|December 29, 2024

概括

肝脏成像报告和数据系统 (LI-RADS) 的主要特征在各种患者因素中始终与肝细胞癌 (HCC) 风险有关. 这表明LI-RADS可以在没有修改的情况下普遍应用于危险人群.

科学领域:

放射学和医学成像学医学成像学
肝病学肝病学是一种肝病学.
在瘤学瘤学.

背景情况:

指导方针表明,肝脏成像报告和数据系统 (LI-RADS) 的适用性在某些肝细胞癌 (HCC) 风险人群中可能有所不同.
关于HCC风险因素与LI-RADS主要特征之间的关联的数据有限.
本研究通过评估这些协会来解决这一差距.

研究的目的:

确定HCC风险因素与CT/MRILI-RADS主要特征之间的关联是否在患HCC风险的个体之间有所不同.
为LI-RADS在风险人群中的普遍应用提供证据.

主要方法:

从2014年到2022年对多个数据库 (MEDLINE,Embase,Cochrane,Scopus) 进行系统的搜索.
对23项研究 (2958名患者) 的个人参与者数据 (IPD) 的元回归分析.
评估LI-RADS主要特征与HCC风险因素 (年龄,性别,肝硬化,HBV) 之间的相互作用.

主要成果:

LI-RADS主要特征与HCC之间的关联在各种HCC风险因素中是一致的.
P值在0.09到0.99之间,表明没有显著差异.
对低偏差研究的敏感性分析证实了初步发现.

结论:

CT/MRI LI-RADS主要特征与HCC风险因素的相关性在风险人群中没有显著差异.
CT/MR LI-RADS应应用于所有系统认为有风险的患者,而无需修改.
这些发现支持LI-RADS用于HC风险评估的标准化使用.

关键词:

图像扫描/MRI可以进行.在HCC中,HCC是HCC,HCC是HCC.李-拉德斯 (LI-RADS) 公司主要特征主要特征主要特征有关风险因素的风险因素.

更多相关视频

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...